BSE: 524506 - Coral Laboratories Limited

Yield per half year: -19.84%
Dividend yield: +0.23%

Share chart Coral Laboratories Limited


About Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally.

more details
The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.23
Дивиденд ао 2
Сайт http://corallab.com
Цена ао 757.6
Change price per day: -2.54% (747.35)
Change price per week: -1.55% (739.8)
Change price per month: -9.81% (807.6)
Change price per 3 month: -4.44% (762.2)
Change price per half year: -19.84% (908.6)
Change price per year: +93.76% (375.9)
Change price per 3 year: +114.98% (338.8)
Change price per 5 year: +432.03% (136.9)
Change price per 10 year: 0% (728.35)
Change price per year to date: -7.8% (789.95)

Underestimation

Title Value Grade
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
EV/EBITDA 0 0
Total: 8

Efficiency

Title Value Grade
ROA, % 8.31 3
ROE, % 9.5 3
Total: 2

Dividends

Title Value Grade
Div yield, % 0.23 0.58
DSI 0.9286 9.29
Total: 1.91

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 16.32 3
Yield Ebitda, % 0 5
Yield EPS, % 121.44 10
Total: 7.6

Head Job title Payment Year of birth
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 years)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 years)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

Address: India, Mumbai, #3B Patanwala Industrial Estate - open in Google maps, open in Yandex maps
Website: http://corallab.com